Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition

Am J Respir Crit Care Med. 2018 Dec 1;198(11):1451-1453. doi: 10.1164/rccm.201807-1250LE.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / immunology*
  • Antineoplastic Agents, Immunological / immunology*
  • Female
  • Humans
  • Immunotherapy / methods
  • Middle Aged
  • Recurrence
  • Tuberculosis / immunology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab